CCC 2017 October 21 - 24, 2017 - Vancouver, BC
Dr. David Agulnik is an Emergency Medicine Physician at St. Paul's and Mount St. Joseph's hospitals in Vancouver, BC and Clinical Assistant Professor in the UBC Department of Emergency Medicine. He also works for the British Columbia Emergency Health Service both as the Local Medical Consultant for downtown Vancouver as well as an EMS Physician Online Support (EPOS) physician.
Dr. Anderson is a Professor of Medicine at the University of Calgary, Head of the Department of Cardiac Sciences and the Director of the Libin Cardiovascular Institute of Alberta. He is the current Merck Chair for Cardiovascular Research.
Dr. Anderson was awarded his medical degree from the University of Calgary in 1985 and then undertook residency training in Internal Medicine, Cardiology and Interventional Cardiology in Calgary. He pursued further research training in coronary physiology at the Brigham and Women’s Hospital at Harvard Medical School and then returned to Calgary. He has been on staff since 1995.
Dr. Arora was born in London, Ontario and obtained a Baccalaureate of Arts degree from the University of Western Ontario. From there, he next achieved his Medical Doctorate from the University of Toronto in 1996 before moving to Dalhousie University in Halifax, Nova Scotia to undergo his Cardiac Surgery Residency. During his time in his residency in Dalhousie, he completed a Doctorate of Philosophy in the Department of Anatomy/Neurobiology in the field of neurocardiology. After completing two further years of training at the University of Calgary, in Calgary, Alberta, Dr. Arora became the first Cardiac Surgeon in Canada to also complete a fellowship in Critical Care Medicine in 2006. Dr. Arora joined the Cardiac Sciences Program and the Section of Critical Care Medicine at the University of Manitoba as an Academic Clinician-Scientist in 2006 where he has an active clinical research program.
Dr. Arora’s current research interests have concentrated on the care of the critically ill cardiac patient. He has specific interests understanding the impact of delirium, depression and frailty in the older adult undergoing cardiovascular surgery and has received funding from the CIHR, HSFC and the Canadian Frailty Network. Dr. Arora has over 130 peer-reviewed manuscripts and book chapters and is an internationally invited speaker for his team’s clinical and research endeavours.
Dr. Anita Asgar is an Interventional Cardiologist working at the Institut de Cardiologie de Montreal since 2009. Originally from Newfoundland, Dr. Asgar completed her medical school and Internal Medicine Residency at Memorial University (1995-2002). She then moved to Dalhousie to pursue her cardiology training in 2002. Following a two year fellowship in Interventional Cardiology at the Institut de Cardiologie de Montreal, she moved across the Atlantic to London, England to complete a fellowship in Structural and Congenital Intervention at the Royal Brompton Hospital as well as a fellowship in Cardiac Magnetic Resonance Imaging.
Recently named as one of the Young Leaders in Interventional Cardiology by the CRT in February 2010, she is a full-time staff Cardiologist at the Institut de Cardiologie de Montreal as well as Director of the Transcatheter Valve Therapy Clinic. She is an active member of the Structural Heart Intervention program performing over 70 transcatheter aortic valve replacements per year, as well as numerous congenital interventions. She recently began the first Transcatheter mitral valve leaflet repair program in Quebec in December 2010 and is the leading physician in Canada with this therapy. Her research interests include the treatment and management of valvular heart disease and cost-effectiveness analysis.
Dr. Adrian Baranchuk, a native of Buenos Aires, Argentina, obtained his MD from the University of Buenos Aires in 1990. After qualifying in Internal Medicine and Cardiology (1995), he completed a Clinical Fellowship in Cardiac Electrophysiology (1997). In 2002 he immigrated to Spain for a Research Fellow. He was appointed as a Clinical Fellow in Electrophysiology at McMaster University in September 2003. Dr. Baranchuk was appointed as an Assistant Professor of Medicine at Queen’s University (2006), promoted to Associate Professor in 2010 and to Full Professor in 2016 (with Tenure). He has founded the EP Training Program in 2007. He is a member of numerous editorial boards (Europace, Annals of Noninvasive Electrocardiology, etc) and reviewer of several journals. He is currently the Editor-in-Chief of the Journal of Electrocardiology. His first book, Atlas of Advanced ECG Interpretation (REMEDICA, UK) represents a big collaboration effort from well-recognized electrophysiologists of all around the world. His second book Left Septal Fascicular Block was released by SPRINGER in 2016 and his iBook “Electrocardiogrpahy in Pracitice: What to do?” has been number 1 in iTunes for several weeks and downloaded more than 1100 times in about 6 months (2016). His last book “Interatrial Block and Supraventricular Arrhythmias: Clinical Implications of Bayes’ Syndrome” was released in January 2017 by CARDIOTEXT. His next book “Clinical Arrhythmology 2nd Edition” will be released in July 2017 by Willey. He has mentored more than 100 students and residents and his publications usually include a Med Student or resident as first author. He is the current Director of the Critical Enquiry course at Queen’s University. He has been elected Member of the Electrophysiology Section Leadership Council of the American College of Cardiology (2017-2020). He lives in Kingston, Ontario, Canada with his wife Barbara and his daughter, Gala.
Dr. Arden Barry is a Clinical Pharmacy and Research Specialist with Lower Mainland Pharmacy Services, and maintains a clinical practice at the Heart Function Clinic at Abbotsford Regional Hospital and Cancer Centre, and Primary Care Clinic at Chilliwack General Hospital. He is also an Assistant Professor (Partner) with the Faculty of Pharmaceutical Sciences at the University of British Columbia.
Jeron J. Bax is professor of Cardiology and Director of non-invasive cardiac imaging, at the department of Cardiology, Leiden University Medical Center, The Netherlands.
He has been working intensively with the European Society of Cardiology (ESC), and is currently serving as President of the ESC.
He has been Associate Editor of the American College Cardiology, and is currently Associate Editor of the European Heart Journal.
He has co-authored numerous scientific articles, has guided many PhD fellows and his main interests of research include imaging in heart failure, stable coronary artery disease, valvular heart disease and atrial fibrillation.
Rob Beanlands is Vered Chair and Head of the Division of Cardiology at the University of Ottawa Heart Institute and The Ottawa Hospital; an international leader in cardiovascular imaging and founding Director of the National Cardiac PET Centre; a Career Investigator supported by the Heart and Stroke Foundation(HSF) and Tier 1 uOttawa Chair in Cardiovascular Imaging. His research on cardiac metabolism, flow and cellular function has led to pioneering translational work that has impacted understanding of disease, application in patient care, health policy and guidelines. He has led multicentre imaging research [PARR2, IMAGE-HF, CAIN (Co-PI)]. He has more than 250 peer reviewed publications. He has served on several committees/advisory boards for government, industry and professional organizations impacting healthcare policies and practice guidelines. He co-directs CCN’s Cardiac PET working group and helped establish CCN’s Cardiac Imaging Committee on which he serves. He also served on the Ontario Appropriate Use of Diagnostics Advisory Panel. He is Secretary of the American Society of Nuclear Cardiology and was recently chair of the HSF Scientific Review Committee. Recent Awards include QEII Diamond Jubilee Medal (2012) for contributions to Canada and Research Achievement Awards (RAA): Hermann Blumgart RAA - Society of Nuclear Medicine (2013); Canadian Cardiovascular Society RAA (2015).
Dr. Matthew Bennett works as a clinical cardiac electrophysiologist in Vancouver as part of the Heart Rhythm BC group. He completed his internal medicine and cardiology training in Vancouver followed by his electrophysiology fellowship in London Ontario.
Dr. David Bewick completed his undergraduate and medical degrees followed by certification in Internal Medicine and Cardiology at Dalhousie University, Halifax, Nova Scotia.
He currently is on active staff at the NB Heart Center where he is the medical director of the Cardiovascular Health and Wellness program and the Heart Function clinic. He is actively involved in medical education including the chair of the NB Heart symposium for the last 27 years along with participating with the Canadian Cardiovascular and Echocardiograpy societies.
Dr. Billia completed her PhD at the University of Toronto and went on to complete her medical degree, including her Internal Medicine and Cardiology training at the Faculty of Medicine, Toronto. She continued with sub-speciality training in Echocardiography and a post-doctoral fellowship at the Campbell Family Institute for Cancer Research, in Dr. Tak Mak’s laboratory. Dr. Billia is on staff at the University Health Network, in the Division of Cardiology. Her practise is focused on the treatment of Heart Failure, Hypertrophic Cardiomyopathy, Mechanical Assist Devices and Transplantation. In addition, she is a partner within the Echocardiography department at the University Health Network.
Callie Bland is an Executive Coach and Registered Nurse.
15 years of experience in both public and private healthcare systems (Canada & USA).
BSc from University of Victoria, BSN from University of BC School of Nursing.
Coaching certifications and designations from the Coaches Training Institute, International Coach Federation and LEADS Canada.
Partners with clients to support them in effective communication, leadership development, workplace relations, career transition, workplace wellness and work/life satisfaction.
Created and facilitated leadership development workshops for physicians, allied healthcare professionals and healthcare leaders.
Facilitates and promotes an organizational culture that leverages the strengths of individuals and optimizes team performance to improve patient care.
Dr Bucciarelli-Ducci MD, PhD, FESC, FRCP is Consultant Senior Lecturer in Cardiology/non Invasive Imaging at the Bristol Heart Institute, University of Bristol since 2010. In Bristol she is the imaging lead of the Bristol National Institute of Health Research (NIHR) Biomedical Research Unit (BRU) of the Bristol Heart Institute.
She is also the co-Director of the Clinical Research and Imaging Centre (CRIC Bristol), a £7.5M research hub for scientists and clinicians, a joint venture between the University Hospital Bristol and the University of Bristol.
Dr Bucciarelli-Ducci is also honorary clinical senior lecturer at the National Heart and Lung Institute, Imperial College.
After graduating in medicine in Rome (2001) and upon completion of cardiology training in Italy (2005), she started to train in cardiac MRI (CMR). She started as a research fellows at the Feinberg Cardiovascular Research Institute, Northwestern University, Chicago, USA (2004-2005), then undergoing a research/clinical fellowship at the CMR Unit of the Royal Brompton Hospital in London, UK (2006-2010). Between 2008-2010 she was also a CMR consultant on the weekend rota at the Heart Hospital/UCLH, UCL rotating in the service with Prof Moon, before taking on her position in Bristol.
In 2012 she was awarded a PhD at Imperial College with a thesis on “Acute and chronic myocardial ischemia by cardiac MRI”.
In 2014 she was nominated as a Fellow of the Royal College of Physicians London and in 2010 a Fellow of the European Society of Cardiology.
She is currently the chair of the CMR section and vice-president of the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC) (Dec 2016- Dec 2018).
She is a keen CMR advocate and course organizer, both nationally and internationally. She has over 90 publications in high ranking peer-reviewed international journals, including JAMA, JACC and Circulation.
Mangeet Chahal, is an Advanced Heart Failure and Transplantation Cardiologist, with fellowship training from The Ohio State University. She currently serves as the Director of the Advanced Heart Failure and Device Program, at the Heart & Vascular Centre for Cardiology, servicing the growing communities on the west side of Toronto; with expertise in mechanical circulatory support, transplantation, critical care and end stage heart failure.
Mangeet holds American board certification as well as Royal College of Physicians and Surgeons of Canada board certification in both cardiology and internal medicine. She has a clinical interest in early echocardiographic markers of right ventricular remodeling and strain patterns in pulmonary hypertension and transplantation patients, and has published several studies in the Journal of International Heart-Lung Transplantation (ISHLT), as well as Journal of the American College of Cardiology (JACC).
Mangeet has served on the American College of Cardiology as the Chair of the Fellows Council for several years, as a successor to her mentors at The Cleveland Clinic, in Ohio. She has been very active in working with American College of Cardiology in Washington, D.C. in regards to implementing several legislative changes that have impacted preventative health, and cardiovascular care in the U.S. She has recently been appointed as a board member of the Canadian Cardiovascular Society Academy, where she continues to demonstrate leadership and a commitment to excellence.
Dr. Annie Chou, MD, FRCPC is a community Adult Cardiologist. She completed her undergraduate studies in Honors Physiology in 2004, obtained her Medical Degree in 2009, completed 3 years of Internal Medicine Residency in 2012, and finished 3 further years of Cardiology Fellowship in 2015, all at the University of British Columbia. Annie has research experience in, and has presented/published on several topics in Cardiology; specifically, Women and Heart Disease, Electrophysiology, Acute Coronary Syndromes, and Addictions and Cardiovascular Disease. Annie has been in practice at the North Shore Heart Centre and Lions Gate Hospital in North Vancouver since 2015.
Dr. Michael Chu is a Cardiac Surgeon at the London Cardiac Institute. He completed his MD at Univeristy of Saskatchewan followed by his residency training at Western Univeristy in London. He completed a fellowship in minimally invasive and robotic cardiac surgery at East Carolina University, Greenville, North Carolina. He subsequently completed further training in Transcatheter Valves at Universitat Leipzig, Leipzig, Germany. He currently specializes in minimally invasive cardiac surgery, transcatheter valves, complex aortic surgery, and complex redo-valve surgery.
As Head of Medical and Scientific Affairs (M&SA) for Bayer Inc., Dr. Shurjeel Choudhri is responsible for contributing to both the Canadian and international business objectives, with timely development, registration, and post-registration scientific/medical support for innovative, safe and effective pharmaceutical products.Dr. Choudhri joined Bayer Corporation in 1999 and has had significant experience with the Bayer US and Global medical organizations. Before assuming his current role as Head of M&SA in Canada, Dr. Choudhri was the Global Clinical Leader, Anti-Infectives with the Bayer Global Clinical Development group. Dr. Choudhri has authored or co-authored over 100 scientific abstracts and has contributed to over 30 publications in peer reviewed journals. He is a passionate advocate for mobile and digital Health and is a member of the Canadian Advanced Technology Alliance (CATA) mobile health advisory board.
Dr. Kim Connelly is a Cardiologist and Clinician Scientist who is both nationally recognized as an expert in human and rodent echocardiography, cardiovascular MRI and the impact of diabetes upon cardiac function. His work has been recognized by winning the “Young Investigator of the Year Award” in 2012 by the Canadian Cardiovascular Society an Early Researcher Award in 2014 and a CIHR New Investigator award in 2014. In 2015 he was awarded the S.C. Verma Young Investigator Award, Heart and Stroke Foundation of Canada/ Richard Lewar Centre of Excellence, Toronto, Ontario, Canada.
Dr. Connelly runs a basic research laboratory at the Keenan Research Centre at St. Michael’s Hospital where he focuses upon basic mechanisms of disease – primarily around the role of pathological extracellular matrix accumulation and the pro-sclerotic cytokine transforming growth factor beta, with a focus upon translating discoveries into therapies in humans. He is the Director of the Krembil Stem Cell Facility at St. Michael’s Hospital and uses stem cell based therapies to improve cardiac and renal dysfunction as a result of diabetes. He is the Chair of macro vascular complications at the Canadian Diabetes Association and is PI on a number of clinical trials involving Novel diabetes drugs and stem cell therapies. He has just taken over as President of Can SCMR. He collaborates extensively not only locally in Toronto but also nationally and internationally – with research support from the HSF of Canada, CIHR and CFI and the Ministry of Ontario.
Dr. Richard Cook is a clinical associate professor of surgery at the University of British Columbia, and is a practicing cardiac surgeon at the Vancouver General Hospital, where he is the director of Robotically-Assisted and Minimal Access Cardiac Surgery. During his training, he completed two fellowships within these fields. His first was with Prof. Christophe Acar in Paris, France within the study of mitral valve repair, and his second with Dr. Randolph Chitwood Jr. in Greenville, USA within the field of robotics and mini-thoracotomy cardiac surgery. His past and present research interests include Atrial Fibrillation, Minimally Invasive Techniques, Mitral Valve Repair, and Transplantation where he has published and presented on numerous manuscripts particularly on those examining Post-Operative Atrial Fibrillation in the Cardiac Surgery Patient. Presently, his research focuses on minimally-invasive delivery of cardiac surgery. He wishes to expand current revascularization options, by offering hybrid revascularization to select patients. He is also working to streamline minimally invasive valve repair techniques such that minimally invasive approaches can be adopted and practiced by a wider range of cardiac surgeons.
Dr. Peggy DeJong received her bachelor’s degree from the University of Waterloo and her medical degree from Queen’s University. Her clinical training consisted of Internal Medicine and Cardiology at Queen’s University. She completed an additional year at the University of British Columbia, Vancouver General Hospital in echocardiography. She joined the Division of Cardiology at Queen’s University in 2014. She currently serves as the Director of the Adult Cardiology Residency Training Program at Queen’s University.
Dr. DeJong’s chief academic interest is medical education. She is working on a Masters in Medical Education from Dundee University, Scotland (supported by the Department of Medicine, Queen’s University). She has also developed the Competency Based Medical Education curriculum and assessments for the Cardiology training program at Queen’s University for the Queen’s University initiation of CBME across all training programs on July 1, 2017.
Pedro J. del Nido
Dr. del Nido graduated with honors in Biochemistry from the University of Wisconsin and received his medical degree at the University of Wisconsin Medical School. He completed his General Surgery residency at Boston University in 1982, and Cardiothoracic Surgery at the University of Toronto in 1985. He then trained as a Pediatric Cardiac Surgeon at The Hospital for Sick Children in Toronto. After completing residency, Dr. del Nido began his career at the University of Illinois in Chicago, and in 1989 went to the Children’s Hospital of Pittsburgh. He returned to Boston in 1994 to work at Boston Children’s Hospital, and became Chief of Cardiovascular Surgery in 2003. He was appointed William E. Ladd Professor of Child Surgery at Harvard Medical School in 2004.
Dr. del Nido’s clinical interests are in congenital valve reconstruction and also recruitment of the hypoplastic left heart for two-ventricle physiology. His laboratory research work aims to develop techniques for performing reconstructive surgery inside the beating heart using 3-D echocardiography guidance. This project is a research partnership with engineering laboratories and industry and proposes to design and implement new technology and instrumentation to facilitate beating heart repair of intracardiac defects, thus obviating the need for open heart surgery.
Phillip James (PJ) Devereaux
Dr. Devereaux obtained his MD from McMaster University. After medical school he completed a residency in internal medicine at the University of Calgary and a residency in cardiology at Dalhousie University. He then completed a PhD in Clinical Epidemiology at McMaster University.
He is the Director of the Division of Cardiology at McMaster University. He is also the Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute. Dr. Devereaux is a full Professor and University Scholar in the Departments of Health Research Methods, Evidence, and Impact (HEI) and Medicine at McMaster University.
The focus of his clinic research is vascular complications around the time of surgery. He is undertaking several large international RCTs and observational studies addressing this issue. He has published >250 peer reviewed papers and >50 book chapters and editorials. He is supported by a Tier 1 Canadian Research Chair in Perioperative Medicine, and he holds the Yusuf Chair in Cardiology at McMaster University.
Dr. Savita Dhanvantari is a Scientist in the Metabolism and Diabetes and Imaging programs at the Lawson Health Research Institute, and Assistant Professor in the Departments of Medical Biophysics and Pathology/Laboratory Medicine at Western University. Her research program focuses on the molecular mechanisms and imaging of metabolic disease.
Dr. Dietz is Victor A. McKusick Professor of Pediatrics in the Institute of Genetic Medicine at Johns Hopkins University School of Medicine and Investigator in the Howard Hughes Medical Institute.
His undergraduate training in biomedical engineering was undertaken at Duke University and his MD degree was received from the Health Sciences University of Syracuse. Clinical and research training in pediatrics, pediatric cardiology, and genetics occurred at Johns Hopkins University School of Medicine.
Dr. Dietz heads a multidisciplinary clinic for the diagnosis and management of individuals with heritable forms of cardiovascular disease, with a special emphasis on Marfan syndrome and related connective tissue disorders. He directs a group of dedicated molecular biologists focused on improvement of the lives of individuals with Marfan syndrome and related disorders through the development of novel diagnostic and treatment strategies.
Dr. Dietz’s research is focused on elucidation of the etiology and pathogenesis of connective tissue disorders that involve the cardiovascular system. Using a human genetics approach, his group identified the genes responsible for multiple syndromic presentations of aortic aneurysm including Marfan syndrome, Loeys-Dietz syndrome and Shprintzen-Goldberg syndrome. His lab is best known for in-depth mechanistic studies that involve the creation and characterization of animal models. This work has firmly implicated the TGFβ signaling pathway in aneurysm progression and has revealed many unanticipated treatment strategies.
Dr. Dietz has received multiple prestigious awards including the Curt Stern Award from the American Society of Human Genetics, the Taubman Prize for excellence in translational medical science, and the Harrington Prize from the American Society for Clinical Investigation and the Harrington Discovery Institute. He is an inductee of the American Society for Clinical Investigation, American Association for the Advancement of Science, Academy of American Physicians, National Academy of Medicine, Association of American Physicians, and the National Academy of Sciences.
Dr. Dipchand received her Doctor of Medicine from the University of Toronto in 1992. She completed her paediatric residency at the Hospital for Sick Children in 1996 in addition to a fellowship in paediatric cardiology in 1999. She then joined SickKids as a staff cardiologist with a focus on heart transplant and echocardiography and remains to this date. She became Clinical Head of the Heart Transplant Program in 2003, Section Head in 2005 and also filled the role of Section Head of Echocardiography from 2005 to 2008. Dr. Dipchand’s research has focused on issues relevant to the care of children with end-stage heart failure and paediatric heart transplantation – most specifically morbidity and mortality-related risk factor assessments. She was President and scientific lead of the Pediatric Heart Transplant Study from 2008-2010 and in 2011 assumed a leadership position as the Associate Director, Pediatric for the International Society of Heart and Lung Transplantation Registry. She has been chair of both the Paediatric and Education Committees of the Canadian Society of Transplantation, and is currently the chair of the American Society of Transplantation Pediatric Community of Practice. She serves on the boards of the International Pediatric Transplant Association and the David Foster Foundation. She is on the Steering Committee of the International Mechanically Assisted Circulatory Support (IMACS) Registry. Dipchand is also the founding president and CEO of the Pediatric Heart Transplant Study Foundation.
Dr. Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto, and a Staff Scientist at the Li Ka Shing Knowledge Institute.He is the immediate Past-President of the Canadian Heart Rhythm Society, Chairman of the Cardiac Arrest Committee, St. Michael’s Hospital, Co-PI on the NIH funded Resuscitation Outcomes Consortium, and serves on the steering committee of multiple multicenter clinical trials in arrhythmia care. He is the Chair of the Canadian Cardiovascular Society Quality Committee.He has published over 350 peer reviewed papers and is Associate Editor of the textbook Electrophysiological Disorders of the Heart.
Dr. Stephen Duffett is an electrophysiology fellow training at Western University (London, ON).
Dr. Ismail El-Hamamsy is a cardiac surgeon with sub-specialization in aortic surgery from the Montreal Heart Institute. Dr. El-Hamamsy completed his residency training at Université de Montréal. He went on to complete a 4-year fellowship at Harefield Hospital in London under Sir Magdi Yacoub. During his fellowship, he completed a PhD on the pathophysiology of aortic valve disease at Imperial College London. He currently is a Canadian leader in Ross procedure and Valve-sparing operations.
Dr. Exner is a cardiologist, heart rhythm specialist. A Professor at the University of Calgary. He holds the position of Medical Director of Cardiac Pacing and Electrophysiology at the Libin Cardiovascular Institute of Alberta, where his focus is on identification of serious and abnormal heart rhythms, optimal treatment and the integration of device therapy in the management and treatment of heart failure. He earned his Doctor of Medicine in 1990 from the University of Saskatchewan, followed by a medical residency at the University of Western Ontario, where he later undertook a device fellowship; a cardiology residency and a cardiac electrophysiology fellowship at the University of Calgary; and a Master’s of Public Health from Johns Hopkins University. Dr. Exner has been published more than 185 times; publications range from peer-reviewed articles, chapters in textbooks, abstracts and many works in leading medical journals.
Dr. Anne Fournier graduated from medical school at the University of Montreal in 1980. After training in pediatrics (1981-1983) and Pediatric Cardiology (1983-1984, 1985-1986) at the CHU Sainte-Justine, she completed a fellowship in pediatric cardiac electrophysiology at Jackson Memorial Hospital, University of Miami, and Texas Children's Hospital, Baylor College of Medicine, Houston. Since 1986, she joined the division of pediatric cardiology at CHU Sainte-Justine as Chief of Electrophysiology section. Dr. Fournier is in charge of pediatric patients with pacemakers and defibrillators. She is a consultant for patients with complex arrhythmias and participated in electrophysiological studies and ablation therapy. Dr Fournier has developed a large network of outreach clinics of pediatric cardiology throughout the province of Quebec, encompassing more than 5,000 visits per year in medical centers affiliated with CHU Sainte-Justine. From another perspective, Dr. Fournier has been involved with the community as a founding member of the Quebec Foundation for Children with Heart Disease, (En Coeur). For her implication, she received the prize for social engagement from the faculty of medicine of the University of Montreal in 2013. She also received the prize for clinical excellence from the Department of Pediatrics of the University of Montreal in 2015. Dr. Fournier participated in numerous clinical research project, is co-author of 20 book chapters, 130 publications and more than 350 scientific presentations. She is responsible for the organization of the provincial annual symposium on congenital heart disease that will be held for the 12th time this year. Since the beginning of her career, she has been a member of Canadian Cardiovascular Society and the Canadian Pediatric Cardiology Association. She has been involved in the Trainee Review Program in Pediatric Cardiology and served as the Congenital Track Captain from 2012 - 2016. She is a member of the CCS Council since 2014.
Shaun G. Goodman
Dr. Shaun Goodman is a Staff Cardiologist and Associate Head in the Division of Cardiology, Department of Medicine, at St. Michael’s Hospital. He is a Professor and Heart & Stroke Foundation of Ontario (Polo) Chair in the Department of Medicine at the University of Toronto. He is an Adjunct Professor in the Department of Medicine at the University of Alberta and a Co-Director of the Canadian VIGOUR Centre (CVC). He is a consultant to the Canadian Heart Research Centre (CHRC). He completed his Doctor of Medicine (1987) at McMaster University (Hamilton, Ontario) and a Masters of Science in Clinical Epidemiology in the Faculty of Medicine and Graduate Department of Community Health at the University of Toronto (1998). He completed his training in Internal Medicine and Cardiology at the University of Toronto. He pursued a three year Heart amp; Stroke Foundation of Canada-funded research fellowship before joining the Division of Cardiology at St. Michael’s Hospital in 1995.
Pishoy completed his undergraduate medical degree at the National University of Galway, Ireland and completed his MSc in Clinical Trials at the London School of Hygiene and Tropical Medicine. He is currently a PGY-2 internal medicine resident at the University of Calgary. He is also currently the outreach team leader on the CCS Trainee Committee. Outside of medicine he enjoys flying and playing volleyball.
Michelle Graham is an Interventional Cardiologist and Professor of Medicine at the University of Alberta. She obtained her MD at the University of Ottawa and followed this with training in Internal Medicine at the University of Western Ontario, and Cardiology at Dalhousie University. She then completed her fellowship in Interventional Cardiology at the University of Calgary.
Dr. Graham’s primary research interests are varied and include cardiac care in the elderly, processes of care, and peri-operative medicine. Much of her work involves the Alberta Provincial Project for Outcomes Assessment in Coronary Heart disease (APPROACH Project).
Dr. Graham has been an active member of CCS for many years, serving on Council and spending two terms as Chair of the Guidelines Committee. She is currently Chair of the Scientific Program Committee.
Peter Guerra is a cardiologist and electrophysiologist at the Montreal Heart Institute and an Assistant Professor of Medicine at the University of Montreal. He completed his internal medicine and cardiology training at McGill University and subsequently became a fellow in the electrophysiology program at the Montreal Heart Institute. He then spent two years at the University of California in San Francisco where he specialized in atrial fibrillation ablation.
Since returning to Montreal in 1999, his research interests have centered on novel techniques for atrial fibrillation ablation, including new imaging modalities and energy sources such as beta-radiation and cryothermy. He has been highly involved in teaching of the residents and fellows, and was a member of the education committee of the Montreal Heart Institute and was head of the electrophysiology training program. He was named Chief of Cardiac Electrophysiology at the Montreal Heart Institute in 2006.
He is an active participant in the Canadian Cardiovascular Society and the Canadian Heart Rhythm Society. From October 2008 to 2010 he was president of the Canadian Heart Rhythm Society and is still involved in the Education Committee. He has chaired the Royal College Committee for the diploma program in Electrophysiology. He is currently serving on the executive committee of the Canadian Cardiovascular Society as Secretary.
As of July 2014, Dr. Guerra is Chief of the Medicine and Cardiology Departments at the Montreal Heart Institute and holder of the Philippa and Marvin Carsley Chair of Cardiology at the University of Montréal.
Dr. Linrui Guo was born in a family of practicing physicians. After completing his medical and cardiac surgery training in China, he was offered a clinical research fellowship at The University of Toronto. He worked at Sunnybrook Hospital and Toronto General Hospital for about a year and a half, after which he further trained as a Clinical Fellow at Victoria Hospital until 1997. Dr. Guo returned to China to set up a cardiovascular surgery program and led a heart institute – Asia-Pacific, now Guang-Zhou Heart Institute in Guang-Zhou from 2000 to 2005. He has been recruited back to Western since January 2005 and he is currently the Post Graduate Program Director. Recently he has formed a partnership with the West China School of Medicine to help patients with valvular heart diseases. Dr. Guo was part of the surgery team that performed the world’s first successfully performed aortic valve bypass using a specialized Aortic Valve Bypass (AVB) device.
Dr. Ansar Hassan is a Cardiac Surgeon in Saint John, New Brunswick. He is an assistant professor at both Dalhousie University and Memorial Univeristy. He completed his residency training at Dalhousie University. He has a PhD in Community Health and Epidemiology from Dalhousie University. Dr. Hassan completed a fellowship in minimally invasive cardiac surgeon at East Carolina University in Greenville, North Carolina. His research interests include clinical outcomes research in cardiac surgery.
Jeff Healey is the Director of Arrhythmia Services and Associate Professor of Medicine at McMaster University in Hamilton, Ontario Canada. He is also a senior scientist at the Population Health Research Institute. Dr. Healey is the Principal Investigator and Chair of the Canadian Stroke Prevention Intervention Network (CSPIN), a ten-year network grant funded by the Canadian Institutes of Health Research, The Heart and Stroke Foundation of Canada and Industry. CSPIN will conduct a series of clinical trials related to atrial fibrillation and stroke prevention and will also support the development of new Canadian researchers in this field. He is the past co-chair of the Canadian Cardiovascular Society’s Atrial Fibrillation Guidelines Committee and past chair of the Cardiac Care Network of Ontario’s Heart Rhythm Working group.
Dr. Healey was the lead author of the ASSERT trial, which was published in the New England Journal of Medicine in 2012 and demonstrated the increased stroke risk associated with sub-clinical atrial fibrillation detected by pacemakers. Thomson-Reuters recognized ASSERT as the 38th most-cited scientific publication in 2012. He was also the lead author of the SIMPLE trial, published in the Lancet in 2015, which demonstrated that implantable defibrillators could be safely inserted without performing intra-operative defibrillation testing, and the RELY AF cohort study, a 15,000-patient worldwide registry, published in the Lancet in 2016, examining the causes, treatment and outcomes in patients with atrial fibrillation.
Dr. Christine Herman is a Cardiovascular Surgeon at Dalhousie University, Halifax. She has expertise in aortic surgery, vascular surgery and endovascular procedures. She completed her medical school and residency training at Dalhousie University. She has a Master's in Community Health and Epidemiology from Dalhousie University. Dr. Herman completed both a vascular fellowship at McGill University, with a focus on endovascular repairs. She also completed fellowships in both TAVI and complex open aorta repair at University of Pennsylvania. She is currently interested in outcomes research in patients with both thoracic aortic and abdominal aortic disease.
Professor Gerhard Hindricks was born in Rheine/Westphalia, Germany. He attended the Westfälische Wilhelms University in Münster where he completed his medical education. After graduation he worked under Professor Günter Breithardt at the Department of Cardiology and Angiology at the University of Münster (1989 – 1998). He is specialist for Internal Medicine and Cardiology. Since April 1998, he works as Co-Director (initially) and then Director of the Department of Electrophysiology at the Heart Center of the University of Leipzig, which is one of the biggest Electrophysiology Departments worldwide. Since 2005 he has been a Professor of Medicine at the University of Leipzig. His particular scientific areas of interest are cardiac electrophysiology, catheter ablation, cardiac pacing, atrial fibrillation, ventricular tachycardia, and sudden cardiac death. He has more than 400 publications in German and international journals, monographies and textbooks. He is Deputy Editor of the European Heart Journal and Reviewer for numerous high-impact medical journals.
Prof. Hindricks is a very active member of the German and of the European Society of Cardiology. Since June 2015, he is the current President of the European Heart Rhythm Association.
He is also General Manager of the Leipzig Heart Institute, a major Research & Development Project in Saxony, Germany.
Dr Gabrielle Horne is a graduate of St Thomas’s Hospital Medical School in London, UK. She also has a PhD in cardiovascular physiology from the University of Calgary. She completed her Internal Medicine training in Calgary, and her cardiology training at Dalhousie University in Halifax, NS. She did a fellowship at the Krannert Institute of Cardiology in Indiana before returning to a staff position at Dalhousie in November 1998. She is an Associate Professor of Medicine (cardiology) and Biomedical Engineering, and a cardiologist at Capital Health. She is the Medical Coordinator of the Maritime Connective Tissue Clinic. Her interests include hereditary aneurysm syndromes and connective tissue disorders, heart failure, cardiac mechanics, echocardiology and image processing software development.
Victor F. Huckell
Dr. Victor F. Huckell earned his degree in Medicine from the University of British Columbia, Canada and is certified by the Royal College of Physicians and Surgeons of Canada in both Internal Medicine and Cardiology (FRCPC).
Dr. Huckell serves as a Clinical Professor of Medicine (Cardiology) at the University of British Columbia and is on Staff at the Vancouver General Hospital. He has continued to receive numerous awards for teaching endeavors; including the University of British Columbia Excellence in Teaching Award (Killam Award), the St. Paul’s Hospital Bruce Shallard Lecturer award (Distinguished Teaching), the Canadian Cardiovascular Society Distinguished Teacher Award, the UBC Division of Cardiology Clinical Mentor Award, the Canadian Cardiovascular Society Visionary Award twice, the UBC Department of Medicine Master Teacher Award, the UBC Clinical Faculty Award for Career Excellence in Clinical Teaching, and the Queen Elizabeth II Diamond Jubilee Medal.
He is a Clinical Professor of Medicine at the University of British Columbia. In this role he runs a busy teaching office, Cardiology practice, and has had the privilege of mentoring over 570 Residents and 350 4th year Medical Students from 17 countries to date. He is the past Director of Education and is on the research committee for the UBC Division of Cardiology.
In addition to his teaching responsibilities, Dr. Huckell has delivered more than 2100 presentations on Cardiology and patterns of practice. He has co-authored four National Practice Guidelines (Adult Congenital Heart disease, Women and Cardiovascular Health, Peripheral Arterial Disease, Stable Ischemic Heart Disease), 53 peer reviewed articles, 67 abstracts, two textbook chapters and 41 non peer reviewed papers. He has also created 59 special education projects including enduring materials such as teaching DVD’s, CD’s, and educational facilitation guides.
Dr. Isaac was a staff nurse and clinical educator before completing medical school and Internal Medicine residency at the University of Calgary, cardiology/echocardiography fellowship at Northwestern University (Chicago), and research fellowship in heart failure. She is Professor of Medicine (University of Calgary), director of Cardiac Transplantation / Mechanical Circulatory Support, Clinical Heart Failure research program collaborator, and is active in medical education. As immediate past-president of the Canadian Cardiac Transplant Network, she remains active in transplantation / donation at a national level. Her interests include Global Health Development, as co-director of the Guyana Program to Advance Cardiac Care, Guyana, South America.
Dr. Davinder S. Jassal was born in Thompson, Manitoba, obtained an International Baccalaureate Degree at Sisler High School in Winnipeg, and graduated from the University of Manitoba with an MD in 1998. He completed a residency in Internal Medicine at the University of Manitoba from 1998-2001 and then a residency in Cardiology at Dalhousie University in Halifax, Nova Scotia, Canada from 2001-2004. Subsequently, he completed a clinical and research fellowship in multimodality cardiac imaging from 2004-2006, specializing in echocardiography, computed tomography, and MRI at Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, US.
Dr. Jassal joined the University of Manitoba in 2006 as an Academic Clinician Scientist, where half of his time is devoted to patient care in the Coronary Care Unit and cardiac imaging and the other half devoted to translational research. Currently, as a distinguished contributor to the field of noninvasive cardiovascular imaging, he holds numerous academic and administrative positions at the University of Manitoba. Dr. Jassal is Associate Professor of Medicine, Radiology and Physiology; Principal Investigator of the Cardiovascular Imaging Laboratory in the Institute of Cardiovascular Sciences at the St. Boniface General Hospital and Research Centre; Program Director of the Adult Cardiology Residency Training Program; Medical Director of the WRHA Coronary Care Unit; Co-director of the WRHA Cardiac CT and MRI programs; and Postgraduate Cardiology Research Director. Additionally, Dr. Jassal holds affiliated scientist positions with both the Institute of Biodiagnostics at the National Research Council of Canada and the Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), and is a cofounder of the Cardiovascular Research and Health Outcomes in Manitoba (CHARM) research group.
Dr. Jassal holds the Heart and Stroke Foundation of Canada New Investigator. He was recently nationally awarded the Royal College of Physicians and Surgeons of Canada Mentor of the Year Award, Canadian Cardiovascular Society Young Investigator Award, the Liam Murphy Young Investigator Award from the Department of Internal Medicine, and the University of Manitoba Rh Award for Outstanding Contributions to Scholarship and Research in the Health Sciences Category. Dr. Jassal has secured grant support from a total of 26 local, provincial and federal agencies amounting to 3.0 million dollars in funding. With over 350 peer reviewed publications consisting of original research, editorials, chapters, and abstracts, he has published in high impact journals including the New England Journal of Medicine, Circulation, Journal American College of Cardiology, and the European Heart Journal.
Dr. John Jue is a Clinical Associate Professor in the department of cardiology at the University of British Columbia (UBC). He has also served as Director of Cardiac Ultrasound and Director of Non-invasive Cardiology at Vancouver General Hospital. He received his B.S.c and M.D from UBC Dr. Jue did his fellowship in internal medicine at the University of Toronto, and his fellowship in cardiology at UBC. He was also a research fellow at the University of California San Francisco.
Academically, his focus has been echocardiography and bedside teaching in the Cardiac Care Unit. Since 1992, he has been involved in the echo lab, training every cardiology fellow. In addition, radiology residents rotate in and he has trained a number of community radiologists and physicians. On a less formal basis, Dr. Jue has educational sessions with the rest of the cardiac anaesthetists. His training includes not only pathophysiology of the underlying cardiovascular disease, but understanding the physics and imaging planes of ultrasound, technical skills required in imaging transthoracic echoes, transesophageal echo and stress echo.
Dr. Jue has served as a Board Member of the Canadian Society of Echocardiography, and a Governor for the B.C. chapter of the American College of Cardiology, He is a Fellow of the American College of Cardiology and a member of the American Heart Association and the American Society of Echocardiography.
Dr. Dimitri Kalavrouziotis is an attending cardiac surgeon and Assistant Professor at the Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) in Quebec City. After medical school at McGill University in his native city of Montreal, he completed his residency at Dalhousie University and went on to specialized fellowships at IUCPQ and Cleveland Clinic. His interests include heart transplantation and mechanical circulatory assist devices, minimal-access mitral valve repair, and atrial fibrillation surgery. He is also active in database-driven clinical outcomes research as well as prospective studies focusing on optimizing outcomes following coronary and valvular surgery as well as surgery for end-stage heart failure.
Dr. Malek Kass obtained his MD from the University of Manitoba in 2002. He then continued with Internal Medicine training at the University of Manitoba, prior to pursuing Cardiology specialty training at the University of Ottawa Heart Institute. Subspecialty training in Interventional Cardiology and Cardiac Imaging/CT was completed at the Ottawa Heart Institute in 2010. He is currently an Assistant Professor of Medicine and Radiology at the University of Manitoba, primary appointment at St. Boniface General Hospital. He is the Director of Structural Intervention and the Program Director for Adult Cardiology at the University of Manitoba. His research interests include trans catheter aortic valve implantation, structural intervention, as well as complex coronary intervention.
Dr. Sheila Klassen is currently doing a clinical echocardiography fellowship at the Massachusetts General Hospital in Boston and research fellowship at Harvard. She completed her internal medicine at McMaster University and general cardiology training at the University of Calgary. She has been involved in global health research and missions since medical school. She was involved in cardiology service implementation in Guyana with Dr. Isaac since 2014. Her research interests include rheumatic heart disease, cardiovascular disease in HIV positive individuals, and cardiac care/service delivery in low income settings.
Dr. Krahn’s expertise is in management of cardiac arrhythmias. Current research interests include investigation of genetic causes of arrhythmias, causes of loss of consciousness and implantable arrhythmia devices. Dr. Krahn has research funded by the Heart and Stroke Foundation and the Canadian Institute of Health Research. He has published 368 papers in peer-reviewed journals. He is an Associate Editor for Heart Rhythm, and sits on the Editorial Board of the Canadian Journal of Cardiology and the Journal of Cardiovascular Electrophysiology. He is Vice President of the Canadian Cardiovascular Society. He is the Sauder Family Chair and UBC Chief of Cardiology, and the Paul Brunes Chair in Heart Rhythm Disorders. He is on the Board of Trustees of the Heart Rhythm Society as their Secretary Treasurer. He is married with a 25-year-old daughter, and enjoys skiing, hiking, golf and a good glass of red wine.
Dr. Jessica Laks did her medical school at the University of Ottawa and then ventured to Winnipeg where she completed her pediatrics residency at the University of Manitoba. She is currently a pediatric cardiology fellow at the Hospital for Sick Children in Toronto.
Throughout my training and during my career as a PI both in France and in Canada, I have developed a broad expertise on different aspects of vascular remodeling and atherosclerosis. My research has spanned endothelial function, monocyte-endothelial interaction, and immune cell activation in the context of atherosclerosis. Starting from my early work investigating endothelial permeability (during my PhD in Pharmacology at the University of Sherbrooke), I gradually explored vascular signaling (post-docs in Paris and at the University of Rochester), and eventually progressed to studying leukocyte infiltration in the vessel wall.
In 2001, I was appointed Charge de Recherches at INSERM and subsequently Directeur de Recherches. I remained in Paris until 2007, when I was recruited at McGill. Along the way, I established a variety of in vitro, ex vivo, and in vivo techniques unique to my laboratory, that allow us to better understand how different cell types interact in atherosclerosis, and how this interaction can be modified by the environment. For example, we created a new model of ex vivo mouse carotid artery organ culture, which allows us to maintain vessels in a specified, controlled environment for many days, while benefiting from the native vascular cell/matrix interactions which are so crucial for cells to react as they would in the animal. Using this system, we identified the signalling cascades that link hypertensive conditions to atherosclerosis susceptibility. I also developed a new mouse model of carotid artery-jugular vein arteriovenous fistula, to investigate how blood flow infuences vascular remodelling and leads to atherosclerotic plaque regression. My work has been greatly enriched by the many collaborations and friendships made along the way.
Jonathon A. Leipsic, M.D., F.R.C.P.C. F.S.C.C.T is the Chairman of the Department of Radiology for Providence Health Care and the Vice Chairman of Research for the UBC Department of Radiology. He is an Associate Professor of Radiology and Cardiology with the University of British Columbia. Dr Leipsic is also a Canada Research Chair in Advanced Cardiopulmonary Imaging. Dr. Leipsic has over 270 peer reviewed manuscripts in press or in print, over 200 scientific abstracts, and editor of 2 textbooks. He speaks internationally on a number of cardiopulmonary imaging topics with over 120 invited lectures in the last 4 years. He is the President of the Society of Cardiovascular CT, the largest international society dedicated to Cardiac CT.
Dr. Shuangbo Liu is currently an Interventional Cardiology fellow at St. Michael’s Hospital in Toronto. Concurrently, she will be completing a thesis-based Masters in Science (Epidemiology) at Harvard University (2017-2019). Dr. Liu obtained her high school diploma and International Baccalaureate Diploma from Silver Heights Collegiate Institute (2003), Winnipeg. In 2007, she obtained a Bachelor of Science from the University of Manitoba, followed by a MD degree in 2011. Dr. Liu completed Internal Medicine residency from at the University of Manitoba (2014). She continued her training with a Cardiology residency (2014-2017) where she was the chief cardiology resident.
During her time in residency, Dr. Liu successfully balanced clinical, academics and research endeavours. She was active on several committees including the Cardiology Unit Quality Improvement Committee, the Manitoba TAVI Program working group and the Manitoba Acute Coronary Syndrome Network committee. During her time in Cardiology, Dr. Liu received over 14 research and teaching awards and had over 12 publications. As well, she presented her research at national and international conferences. Her research interests are in improving care in patients with acute coronary syndrome in Manitoba, with a focus on epidemiology and outcomes research. Dr. Liu’s career goals are to become a clinician scientist in interventional cardiology.
Dr. Carly Lodewyks was born and raised in Winnipeg, Manitoba. She completed a Bachelor of Science and Doctor of Medicine at the University of Manitoba. Currently she is a PGY3 resident in the Cardiac Surgery Program at the University of Manitoba and is completing a Master's degree in Community Health Sciences focusing on the epidemiology of aortic diseases.
Dr. Gary Lopaschuk obtained his BSc (Pharmacy) and MSc and PhD (Pharmacology) degrees from the University of British Columbia, before completing post-doctoral work at The Milton S Hershey Medical Centre in Philidelphia. He then joined the Departments of Paediatrics and Pharmacology at the University of Toronto, before transitioning to the University of Alberta where he currently holds the title of Distinguished University Profession. He is also an AHFMR Scientist. His research lab focuses on the regulatory pathways involved in energy metabolism in the heart, particularly the integrated regulation of fatty acid oxidation and carbohydrate metabolism in both the normal heart, the heart of a diabetic, and the reperfused ischemic heart. He has published over 400 manuscripts and book chapters, and delivered over 250 invited lectures nationally and internationally. He is also an editorial board member of journals such as Circulation Research and Journal of Clinical Investigation, and holds 146 patents.
GB John Mancini
Dr. G. B. John Mancini received his MD degree from the University of Toronto (1977), completed residency at Toronto General Hospital and a Cardiology and Research Fellowship at the University of California at San Diego. After a year as Clinical Assistant Professor there, he joined the University of Michigan in 1983, where he became a tenured Professor and the Chief of the V.A. Section of Cardiology and Associate Chief of the University of Michigan, Division of Cardiology. He then became Chair of Medicine at the University of British Columbia, 1992-2002.
Dr. Mancini is now a tenured Professor of Medicine at the University of British Columbia and directs an imaging-based research program (Cardiovascular Imaging Research Core Laboratory, CIRCL). This program has been actively funded for over 30 years, originating at the University of Michigan and transferred to UBC in 1992. Dr. Mancini’s interest focuses on the integration of multi-modality cardiac imaging in multicenter clinical trials for assessment of structural and functional aspects of coronary atherosclerosis and for primary and secondary cardiovascular risk reduction.
He is a Fellow of the American College of Cardiology, Governor of the American College of Cardiology (British Columbia), a member of the Circulation Council of the American Heart Association, Past President of the Canadian Society for Clinical Investigation, past Editorial Board Member of the Journal of the American College of Cardiology and the American Journal of Cardiology. He reviews for many journals and is currently a member of the editorial boards of the Canadian Journal of Cardiology, and the International Journal of Cardiac Imaging. He is a co-section-Editor of the CJC Clinical Practice and Training Section.
Dr. Mancini remains in active practice in the Vancouver Hospital Cardiology Outpatient Clinic, as well as the St. Paul's Hospital Healthy Heart Prevention Program/Lipid Clinic.
Dr. Jeanne Macleod is a Staff Emergency Physician at St Paul's Hospital in Vancouver, BC. She is also the Providence Health EM Simulation Director and a Clinical Associate Professor at UBC.
Alexis Matteau, MD, MSc, FRCPC is a clinical assistant professor at Université de Montréal and an interventional cardiologist at the Centre hospitalier de l’université de Montréal (CHUM) and Charles-Lemoyne hospital. After completing his medical training and cardiology fellowship at the Université de Montréal, he pursued an interventional cardiology fellowship at the Brigham and Women’s Hospital, Boston, USA. He also holds a degree in epidemiology from the Harvard School of Public Health. He is currently the co-director of the CHUM CTO PCI program. His research interests focus on the pharmacoepidemiologic/pharmacoeconomic evaluation of new drugs in cardiovascular disease and evaluation of novel technologies in the field of interventional cardiology.
Dr. Michael McGillion is an Associate Professor and holds the Heart and Stroke Foundation/Michael G. DeGroote Endowed Chair of Cardiovascular Nursing Research at the McMaster University School of Nursing. He is an internationally-recognized researcher in the area of persistent forms of cardiac pain such as refractory angina and unrelieved chest pain following successful revascularization procedures. Dr. McGillion was Chair of the Joint Canadian Cardiovascular Society – Canadian Pain Society guidelines for the management of refractory angina, funded by the Canadian Institutes of Health Research (CIHR). His current CIHR-funded research program focuses on remote automated monitoring and virtual recovery support for people recovering from cardiac and vascular surgery, social and psychological predictors of chronic post-surgical pain following cardiac surgery, patient decision support, and web-based knowledge dissemination. Dr. McGillion is an appointed member of the Heart and Stroke Foundation Inaugural Pan-Canadian Council on Mission: Priorities, Advice, Science and Strategy (CoMPASS). He has been recognized for his research and advocacy by receiving the Canadian Pain Society Early Career Award and the McMaster University Arch Award for outstanding contributions to society.
Dr. McKelvie attended the University of Western Ontario, in London Ontario, completing a BSc, MSc, and MD degrees. He subsequently trained in Hamilton and received a PhD from McMaster University. Dr. McKelvie is presently a Professor of Medicine (Cardiology) at Western University in London, Ontario. He was formerly a Professor of Medicine at McMaster University in Hamilton, Ontario, where he ran the heart failure and cardiac rehabilitation programs. At present he is also a Professor Emeritus at McMaster University. At Western University Dr. McKelvie is involved in the Heart Failure Program and the St. Joseph’s Cardiac Rehabilitation and Secondary Prevention Program. Over the years he has been involved with the Canadian Cardiovascular Society Heart Failure Guidelines Committee, including serving as Co-chair and Chair of the committee. He presently chairs the Canadian Cardiovascular Society Heart Failure Quality Indicators Committee and the Cardiac Care Network of Ontario Heart Failure Working Group. Over the course of his career he has been involved in the design and conduct of many studies in the area of heart failure and cardiac rehabilitation; including the supervision of graduate students and research fellows. He continues to be active in these areas of research. Dr. McKelvie has published over 200 peer-reviewed papers, over 200 abstracts and contributed to over 30 book chapters.
Dr. Mehta is a Principal Investigator for both the Acute Coronary Syndrome and the Interventional Cardiology programs at the Population Health Research Institute. He is Professor of Medicine at McMaster University and Director of the Interventional Cardiology program at Hamilton Health Sciences. Dr. Mehta received a Canadian Institutes of Health Research New Investigator Career Award. His research focuses on the role and timing of invasive therapies in patients with acute ischemic heart disease and the evaluation of novel antiplatelet and anticoagulant therapies in these patients. He has led several large pragmatic randomized trials evaluating invasive interventional strategies in patients with acute coronary syndromes. He has also lead multinational randomized trials evaluating novel antiplatelet and anticoagulant therapies to improve outcomes in patients experiencing a heart attack. Dr. Mehta has published 127 original research papers in several medical journals including The New England Journal of Medicine, The Lancet, JAMA, and Circulation. Dr. Mehta’s success in research has earned him a coveted Canada’s Top 40 under 40TM award in 2004.
Dr. Seema Mital is a Heart Failure and Transplant Cardiologist and Head of Cardiovascular Research at the Hospital for Sick Children, Toronto. She is Professor of Paediatrics at the University of Toronto and a Senior Scientist at the SickKids Research Institute. She is also the Heart and Stroke Foundation of Ontario Chair of Cardiovascular Science, and the Scientific Co-Lead of the Ted Rogers Centre for Heart Research. Mital has a strong translational research program focused on genomics, pharmacogenomics and stem cell applications to model childhood heart disease and discover new therapies. She has extensive experience in the genetics/genomics of congenital heart disease and heart failure, personalized medicine and clinical trials. She established the SickKids Heart Centre Biobank, a multi-centre biorepository of children and adults with childhood onset heart disease for genomics research, one of the largest international repositories of its kind. She is the Scientific Co-lead of the Ted Rogers Centre for Heart Research Cardiac Precision Medicine Program established in November 2014.Mital is a Principal Investigator of the CIHR-funded Canadian National Transplant Research Program, and the NIH-funded Pediatric Heart Network. She serves on the Leadership Committee of the Functional Genomics and Translational Biology Council of the American Heart Association, American Heart Association National Peer Review Steering Committee, and the Heart and Stroke Foundation of Ontario Research Advisory Committee. She is Vice-Chair of the American Heart Association Council on Cardiovascular Disease in the Young.
Dr. L. Brent Mitchell obtained his B.Sc. (Hon) in Biochemistry (1972) and his M.D. (1975) degrees from the University of Calgary. After a Fellowship in Clinical Cardiology at Dalhousie University, Halifax, Nova Scotia, he undertook a Fellowship in Clinical Cardiac Electrophysiology at Stanford University Medical Centre, California. He returned to Calgary in 1982. He was the inaugural Head of the Department of Cardiac Sciences at the University of Calgary / Calgary Zone of Alberta Health Services, is the inaugural Director of the Libin Cardiovascular Institute of Alberta, and is presently President of the Canadian Heart Rhythm Society. He was the recipient of the international Heart Rhythm Society Distinguished Teacher Award in 2014 and the Canadian Heart Rhythm Society Annual Achievement Award in 2016. Dr. Mitchell’s clinical practice and research interests are in the area of clinical cardiac electrophysiology, particularly in the clinical science of tachyarrhythmias – their mechanisms, their investigation, and their management. His preferred tool in the science of clinical cardiac electrophysiology is the randomized clinical trial. He has contributed to many pivotal trials in clinical cardiac electrophysiology.
Blandine Mondésert is a cardiac electrophysiologist and Assistant Professor of Medicine at the Montreal Heart Institute, Université de Montréal, Canada. She completed her cardiology training in 2008 followed by two years of training in electrophysiology at Grenoble University (France). She then completed three years of fellowship (2011-2013) in adult cardiac electrophysiology, congenital electrophysiology and lead extraction at the Montreal Heart Institute. Dr Mondésert also spent an additional 6 months in Lille (France) to complete her training in device lead extraction and percutaneous left atrial appendage closure. In 2014, Dr Mondésert returned at the Montreal Heart Institute as a member of the electrophysiology service and she is also involved in the adult congenital heart disease clinic and in the interventional cardiology program. She is highly involved in the arrhythmia research program of the Montreal Heart Institute (randomized trials of catheter ablation for atrial fibrillation and other arrhythmia substrates, cryoablation, and new device technologies). She is a member of the primary panel of the Canadian cardiovascular society guidelines for implantable cardiac defibrillators.
In 1979, Dr. Montaner received his MD with Honours from the University of Buenos Aires, quickly followed by his move to the University of British Columbia for his post-doctoral fellowship and completion of his residency in Internal Medicine and Respiratory Medicine. His excellence in practice earned him the distinction of being the Chief Resident for the Department of Medicine, where he held the position in 1986 and 1987.
It was in 1987 that Dr. Montaner joined the University of British Columbia (UBC) and St. Paul’s Hospital (SPH) as the Director of the AIDS Research Program and the Infectious Disease Clinic. Shortly following this appointment, he received another, as a National Health Research Scholar of Health Canada (NHRDP) in 1988, holding the position for a decade. His dedication to the field has continued; founding and co-directing the Canadian HIV Trials Network. In 1996, he became the Endowed Chair on AIDS Research at St. Paul’s Hospital and UBC, in 1997, he was appointed a Professor of Medicine at UBC. More recently, the United Nations AIDS Programme welcomed him as the Global Advisor on HIV Therapeutics to the Executive Director.
As a researcher, Dr. Montaner has focused his efforts on developing management strategies and antiretroviral therapies for HIV and AIDS patients. He played a key role in establishing highly active antiretroviral therapy (HAART) as the Global Standard of Care, increasing access to HAART for isolated populations like intravenous drug users, and the use of HAART as treatment for multiple drug resitant HIV infections. His pioneering perspective lead to the concept Treatment as Prevention ® (TasP®); now embraces by UNAIDS, PEPfAR, China, France and the US Government. In 2013, the World Health Organization (WHO) fully incorporated TasP into their ARV Guidelines.
Dr. Montaner is a Member of the Order of British Columbia, an Officer of the Order of Canada, has been inducted into the Canadian Medical Hall of Fame, and the Royal Society of Canada – The Academies of Arts, Humanities and Sciences (RSC). On top of being recognized as one of the most valued contributors to antiretroviral research, Dr. Montaner has received the Knowledge Translation Award from the Canadian Institutes of Health (CIHR), the Albert Einstein World of Science Award, the Prix Galien Award, the Hope is a Vaccine Award from the Global Alliance to Immunize against AIDS, and The Queen Elizabeth II Diamond Jubilee Medal for his contributions to the field of HIV/AIDS.
Dr. Shreya Moodley is a pediatric cardiologist at British Columbia Children’s Hospital, Vancouver, Canada. She completed her pediatric and cardiology training through the University of British Columbia and further specialized in advanced cardiac imaging at Stanford University. Her areas of expertise include echocardiography and fetal echocardiography. She also has a strong interest in education and is currently the program director for pediatric cardiology fellowship training at the University of British Columbia.
Dr. Nattel received his MD from McGill University in 1974 and undertook Internal Medicine and Clinical Pharmacology training at McGill between 1974 and 1978. He then obtained Cardiology clinical and basic research training at Indiana University and University of Pennsylvania (1978-1981) before joining the faculty at McGill in 1981. In 1987, he transferred to the University of Montreal and Montreal Heart Institute, where he directed the Research Center between 1990 and 2004. He is presently Paul-David Chair in Cardiovascular Electrophysiology at the University of Montreal and Director of the Electrophysiology Research Program at the Montreal Heart Institute, where he continues to practice clinical cardiology. He is Editor in Chief of the Canadian Journal of Cardiology and Associate Editor of Cardiovascular Research, and is on the editorial board of a number of other journals including Circulation Research, Circulation Arrhythmia and Electrophysiology, Drugs, JACC, JACC Clinical Electrophysiology, Journal of Molecular and Cellular Cardiology, Journal of Cardiovascular Electrophysiology, Journal of Cardiovascular Pharmacology, and Nature Reviews in Cardiology. His research focuses on clinically-relevant mechanisms of cardiac bioelectricity, particularly atrial fibrillation, proarrhythmia, cardiac remodeling, ion channel molecular physiology and mechanisms of drug action. His lab uses a wide range of molecular, cellular, whole-animal and theoretical methods to gain insights into clinically-relevant basic mechanisms and identify novel therapeutic targets. He has also been involved in the initiation and conduct of many clinical trials, and has sat on steering committees and participated in or chaired data monitoring and safety committees. He has supervised over 150 research trainees, published over 600 papers in peer-review journals, has an h-index of 118, and is a Fellow of the Royal Society of Canada (Academy of Science), the Royal College of Physicians of Canada, the American College of Cardiology and the Heart Rhythm Society.
Born in Toronto, Ontario, Dave Nagpal completed his BSc in Physiotherapy at Queen’s University in Kingston in 1998, and went on to complete his MD at the University of Western Ontario in 2004. With an interest in healthcare delivery, he completed a Masters of International Health Management, Economics, and Policy at Bocconi University in Milan, Italy in 2007, and interned at the Cardiac Care Network of Ontario in 2007. Following completion of the University of Western Ontario / London Health Sciences Centre cardiac surgery training program in 2010, and the critical care medicine fellowship in 2011, he completed a surgical heart failure fellowship in 2012 at the Cleveland Clinic. He is a fellow of the Royal College of Physicians and Surgeons of Canada with certifications in Cardiac Surgery and Critical Care Medicine, and is currently Assistant Professor in the Divisions of Cardiac Surgery and Critical Care Medicine at the University of Western Ontario / London Health Sciences Centre in London, Ontario. In 2014 he was appointed Surgical Director of the Advanced Heart Failure and Mechanical Circulatory Support Program, and in 2017 Co-Director of the Cardiac Care Unit. His research interests include acute and chronic cardiac and cardiopulmonary support in the management of heart failure and cardiogenic shock, resuscitation and fluid therapy, and quality improvement in cardiac surgical and critical care outcomes. He has authored or co-authored 26 peer-reviewed manuscripts, and has presented nationally and internationally.
Dr. Parvathy Nair is the program director for core cardiology at the University of British Columbia. She completed her MD at Queen’s University in 1997 followed by Internal Medicine and Cardiology at Queen’s. She subsequently did a 2 year echocardiography fellowship at the University of Toronto supported by the BMS Cardiovascular Fellowship Award while doing an MHPE at the University of Illinois in Chicago. She started on staff at UBC in 2006, where she has filled many roles in education leadership, including Undergraduate Director for the Division of Cardiology, Associate Program Director for Core Internal Medicine (Simulation) and presently, Program Director for Cardiology since 2009. She has also served on the RCPSC Cardiology Exam Board and Executive.
Dr. Ed O’Brien is a Professor at the University of Calgary Cumming School of Medicine and Director of the Vascular Biology Laboratory at the University of Calgary. From 2011-16 he was the Chief of Cardiology for the Calgary zone overseeing clinical cardiology operations at four hospitals including a new site. During his tenure, the division grew from 55 to 75 cardiologists. As well, he was the Director of Research for the Libin Cardiovascular Institute from 2011-15. Prior to that he was a Clinician Scientist at the Ottawa Heart Institute for 17 years, combining a busy interventional cardiology practice with a peer-review funded translational research program. He has a long interest in mentoring, recruiting and fostering the success of cardiology trainees and staff. In 2014, he conducted a survey of Canadian Chiefs of Cardiology examining national trends in employment opportunities for cardiology. Always positive, he sees room for further growth in cardiology, in order to meet the dynamic flux of clinical and academic challenges.
Dr. O’Neill has been a practicing cardiologist since 1990. His health care leadership experience includes Director of the Cardiac Catheterization Laboratory of the Victoria General Hospital and later the QEII Health Sciences Centre in Halifax. He has gone on to become Chief of the Division of Cardiology at the QEII Health Sciences Centre. In 2008 he was recruited as Division Director for the University of Alberta, Division of Cardiology and for the Mazankowski Alberta Heart Institute. In 2012, he became Senior Medical Director for the Cardiovascular Health and Stroke Strategic Clinical Network for Alberta Health Services, and in 2015 became the Associate Chief Medical Officer for all Strategic Clinical Networks in the province of Alberta. He served on Council of the Canadian Cardiovascular Society (CCS) from 1995 until 2000, and on its Executive from 2008-2012, serving as President of the Society between 2010-2012. He served as Chair of the Access to Care Committee for the CCS, and was instrumental in setting the targets for cardiovascular services and procedures, which have been adopted nationally. He also chaired the CCS’ Quality Project Initiative, which established common data-definitions for cardiovascular registries in Canada, as well as the initiative to define national quality indicators for cardiovascular conditions. He also served as Chair of the Quality Collaborative for the Canadian Medical Association.
He has been involved in many cardiovascular reviews, including: the Cardiology Division at McMaster University, the Cardiology Division at St. Michaels Hospital in Toronto, as well as the Cardiac Sciences Program at Sunnybrook Health Sciences Centre in Toronto. In Alberta, he chaired the review for cardiac surgery wait times and proposed mitigating solutions. He also co-chaired the task force to examine expansion of advanced cardiac services including standalone percutaneous coronary intervention to the central zone of Alberta Health Services.
Dr. Zardasht Oqab is a Chief Adult Cardiology Fellow at the University of Calgary. He is originally from Toronto, Ontario where he completed his undergraduate degree in Kinesiology and Health Sciences at York University. He subsequently trained in medicine abroad in Netherlands Antilles and Internal Medicine residency at Queen’s University. He was a member of the CCS Trainee Committee and serves on CANet’s Highly Qualified Personnel Executive Committee. Zardasht is passionate about clinical research and has received grants from the Canadian Stroke Prevention Intervention Network and CANet for his research in atrial fibrillation. Outside of work, he loves to hike the Rocky Mountains in Alberta, travel and experiment tasting variety of cuisines. He is a time management enthusiast and a lifelong student of the game.
Dr. Maral Ouzounian is a Cardiac Surgeon at Toronto General Hospital. She completed her residency training at Dalhousie University. She completed a fellowship in complex aortic surgeon at the Texas Heart Institute in Houston, Texas.
Dr. Glen Pearson is a Professor of Medicine in the Department of Medicine (Division of Cardiology) at the Faculty of Medicine & Dentistry, University of Alberta. He maintains a clinical practice in heart transplant and cardiovascular risk reduction at the Mazankowski Alberta Heart Institute in Edmonton.
Dr. Marc Pelletier is a Cardiac Surgeon and director of the TAVR Program at the Brigham and Women's hospital in Boston. He completed his MD at Dalhousie Univeristy and his residency training at McGill University. He then completed a fellowship in Cardiothoracic Transplantation at Stanford University Medical Centre. He has worked at several hospitals in both Canada and the US. He was the head of cardiac surgery at the New Brunswick Heart Centre for several years before transitioning to the Brigham and Women's hospital in 2016. His current areas of interest include TAVR, complex aortic surgery and minimally invasive surgery. He is also an examiner for the Royal College of Physicians and Surgeons of Canada.
Dr. Ryan Perry is currently the Assistant Scientific Director for the Canadian Institutes for Health Research (CIHR) – Institute for Circulatory and Respiratory Health (ICRH). He is an innovative and trusted medical science professional with more than a decade’s worth of experience in key leadership roles within the health research and innovation system. Dr. Perry has particular expertise in provincial, national and international research and innovation environments, basic biomedical research, mentorship, training & early career development, research impact frameworks, health research administration and managing peer-review funding mechanisms. Dr. Perry completed his PhD in Biochemistry from Dalhousie University, and his MSc in Experimental Medicine and BSc in Physiology (Honours) from the University of Alberta.
Dr. Andrew Pipe graduated from Queen's University in 1974. Formerly Chief of the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute, Dr. Pipe is a Professor in the Faculty of Medicine at the University of Ottawa, and continues his clinical and research activities within the Division.
He is currently involved in clinical research assessing new approaches to smoking cessation, strategies designed to facilitate exercise adoption, and novel initiatives to prevent cardiovascular disease.
Dr. Pipe has addressed audiences in over 30 nations and is frequently consulted on issues related to tobacco use and smoking cessation, physical activity and health, and drug use in sport.
Dr. Pipe is the recipient of the International Olympic Committee's Award for "Sport, Health and Wellbeing" and the Canadian Cardiovascular Society’s Dr. Harold N. Segall Award for distinguished contributions to the prevention of cardiovascular disease. He has been awarded honourary degrees by Queen's University (LLD), Brock University (DSc) and the University of Guelph (DSc). In 2002 Dr. Pipe was named to the Order of Canada.
Dr. Alyssa Power completed her MD at McGill University and her pediatric residency training at the University of Calgary. She is currently a pediatric cardiology fellow at the Hospital for Sick Children in Toronto.
Heather Ross, MD, MHSc, FRCP (C), FACC is a Professor of Medicine at the University of Toronto. She is the Ted Rogers and Family Chair in Heart Function and the Head of the Ted Rogers Centre of Excellence in Heart Function. Dr. Ross is the site lead for the Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre. She is the Director of the Cardiac Transplant Program at Toronto General Hospital. She received her medical degree from the University of British Columbia, Canada, her cardiology training at Dalhousie University, and a postdoctoral fellowship in Cardiac Transplantation at Stanford University, California. She also holds a Masters Degree in Bioethics from the University of Toronto.
Dr. Ross served as the President of the Canadian Society of Transplantation in 2005, as an executive member of the International Society for Heart & Lung Transplantation from 2002 through 2005, and Secretary Treasurer 2007-2010. She has been a Supervisor for the CIHR Training Program in Regenerative Medicine (2002-2014), the Course Director (2007-2014) and Program Advisory Committee Chair and Co-Investigator (2008-2014). She Chaired the ISHLT Master Academy in Heart Failure in 2010. She was Associate Editor for the American Journal of Transplantation (2007-2010) and is an Associate Editor for the Journal of Heart and Lung Transplantation. She served for five years on the Canadian Cardiovascular Society Council, three years on the Canadian Cardiovascular Society Executive and on the Board of the Canadian Cardiovascular Society Academy. She was the Secretary Treasurer for the Canadian Cardiovascular Society Academy 2010-2012. She is currently on the executive of the Heart Failure Society of America and Past President of the Canadian Cardiovascular Society. She has published over 200 articles and won numerous teaching awards.
Dr. Roopinder Sandhu is a Cardiac Electrophysiologist in the Division of Cardiology and Associate Professor of Medicine at University of Alberta. She is also a Visiting Scientist with the Brigham Women’s Hospital, Division of Preventive Medicine. Her main research focus is health services research including a better understanding of arrhythmia epidemiology, identifying gaps in treatment and pursuing strategies to improve outcomes. Dr. Sandhu has received funding from the University Hospital Foundation, Canadian Stroke Prevention Intervention Network, Cardiac Arrhythmia Network of Canada and Heart and Stroke Foundation of Canada.
Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital (VGH) with joint appointment at St Paul’s Hospital. She is a Clinical Associate Professor of Medicine at the University of British Columbia, and Program Director of the Interventional Cardiology Fellowship Program at VGH. She also served as the Head of VGH Cardiology Clinical Trials Research. She is an active clinician, researcher and educator.
She was awarded Canada Scholar and the Dean’s Entrance Scholarship for Natural Sciences at Simon Fraser University for her undergraduate degree. She obtained her medical doctorate at the University of Ottawa, graduating summa cum laude. She completed her Internal Medicine and Cardiology residencies at the University of British Columbia, and served as chief cardiology fellow. She then completed her Interventional Cardiology fellowship training at Cleveland Clinic Foundation, which encompassed carotid, peripheral and structural training. She has been an active staff with the Division of Cardiology at VGH and St Paul’s Hospital since 2004. She is also a physician proctor for left atrial appendage (LAA) closure with the WATCHMAN and Amplatzer Cardiac Plug/Amulet devices.
Dr. Saw is a pioneer and leader in research and management of spontaneous coronary artery dissection (SCAD) (http://scad.ubc.ca), and is the principal investigator of the Canadian Institutes of Health Research (CIHR) funded multi-center prospective Canadian SCAD Study, and the Heart and Stroke Foundation funded Canadian SCAD Genetic Study. Her other research interests include LAA closure, non-atherosclerotic coronary artery disease (including coronary fibromuscular dysplasia), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral arterial disease and intervention. She is also the principal investigator of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has authored over 200 peer-reviewed publications, including scientific research manuscripts, review papers, book chapters and abstracts. She is also the editor of three textbooks on LAA closure and carotid artery stenting.
Dr. Tara Sedlak received her Doctor of Medicine, Internal Medicine Residency and Cardiology residency from the University of British Columbia. She also completed a fellowship at Cedar Sinai Medical Centre in Los Angeles, California on women’s heart health pacticularly focussing on chest pain syndromes in women with no significant coronary artery disease. Dr. Tara Sedlak practices General Cardiology at Vancouver General Hospital and BC Women’s Hospital and is the director of the Leslie Diamond Women’s Heart Health Clinic. Her research interests include etiologies of myocardial infarction and chest pain in women with normal coronary arteries and therapeutic strategies in microvascular coronary dysfunction and coronary vasospasm.
Dr Seifer is an adult cardiologist practicing at St Boniface Hospital in Winnipeg, Manitoba. She obtained her medical degree from the National University of Ireland, Galway in 1992. Following a residency in internal medicine and cardiology, she completed her fellowship in arrhythmia in the United Kingdom at Newcastle University in 2001. She is currently the Medical Director, Cardiology, Medical Director, Arrhythmia Service, Winnipeg Regional Health Authority and Associate Professor, Faculty of Health Sciences, College of Medicine, University of Manitoba. She has won several teaching awards at both Undergraduate and Postgraduate levels including the inaugural Professionalism award from the PARIM (Professional Association of Residents and Interns of Manitoba. She has supervised over 30 resident research projects in the past 10 years with over 50 abstracts and publications during this time.
Dr. Chris Simpson is Professor of Medicine and Chief of Cardiology at Queen’s University as well as the Medical Director of the Cardiac Program at Kingston General Hospital / Hotel Dieu Hospital. He is the Past-President of the Canadian Medical Association (CMA). As of September 1, 2016 Dr. Simpson has been appointed as Vice-Dean, Clinical, School of Medicine and Medical Director, SEAMO.
A New Brunswick native, Dr. Simpson obtained his MD in 1992 from Dalhousie University, and completed Internal Medicine and Cardiology training at Queen’s. He subsequently completed a Heart and Stroke Foundation Research Fellowship in Cardiac Electrophysiology (heart rhythm disorders) at the University of Western Ontario under the supervision of Dr. George Klein.
Dr. Simpson’s primary professional interest is health policy – particularly access to care. He serves as the Chair of the Wait Time Alliance (WTA) and as Chair of the Canadian Cardiovascular Society's (CCS) Standing Committee on Health Policy and Advocacy. He is the Lead for the Southeast (Ontario) Local Health Integration Network (LHIN) Cardiovascular Roadmap Project. He serves on the executive of the CCS (Member-at-Large), on the Cardiovascular Care Network (CCN) Board of Directors, and is an American College of Cardiology (ACC) Governor.
He served as the first President of the Canadian Heart Rhythm Society and was a founding executive member of the International Coalition of Pacing and Electrophysiology Organizations (COPE). He sits on numerous editorial boards and advisory committees, and has chaired or been a member of several national and international consensus conferences, including serving as co-chair of the CCS Consensus Conference on Medical Fitness to Drive and Fly. He is a past recipient of the Canadian Medical Association’s Award for Young Leaders.
Dr. Singal completed his Cardiac Surgery training with the University of Manitoba during which time he obtained his M.Sc. in Surgery conducting experiments on ‘biologically variable’ cardiopulmonary bypass in a porcine model of deep hypothermic circulatory arrest. He followed this with his Critical Care certification at the University of Western Ontario before starting practice at the St. Boniface General Hospital. While at Western he spent an intensive 6 months understanding atrial fibrillation (AF) from the pioneering electrophysiology group there.
On his return to Manitoba he has developed a diverse academic practice in Surgery and ICU with an interest in program development, research and education. Specifically related to arrhythmias, he standardized the Manitoban approach to surgical ablation of atrial fibrillation using a cryothermy technique. He is actively engaged in research relating to thromboembolism in Cardiac Surgery patients with AF and working with national and international colleagues to develop a research platform to improve the understanding of the clinical benefit of surgical ablation of AF.
Dr. Singal is the Head of the Surgical Heart Failure program in Manitoba which is responsible for ECMO and VAD support for patients with cardiorespiratory failure in the acute and chronic setting. His practice in surgery also includes mitral valve repair, minimal access for aortic valve and ascending aortic procedures and selected off-pump coronary artery bypass. He is a founding member of the Canadian Cardiovascular Critical Care Society. Finally, as of 2015 he has been the Cardiac Surgery Residency Program director at the University of Manitoba working to standardize residency education and training milestones within the program to advance the residency training experience and effectiveness.
Dr. Stuart J. Smith received his medical degree from McMaster University in Hamilton, Canada in 1986. He did his Postgraduate Training in Internal Medicine and Cardiology at the University of Western Ontario. In addition, he has done postgraduate training in Infectious Disease & Immunology at the Hospital For Sick Children; and Clinical Epidemiology at the University of Western Ontario.
Dr. Smith worked as a Staff Cardiologist and Associate Professor (Medicine) at the University of Ottawa Heart Institute. He was the Director of the Heart Failure Clinic at the Heart Institute and a member of the Cardiac Transplant Team. His particular areas of interest are the therapeutic management of patients with advanced heart failure with a particular emphasis on surgical options; organization of heart failure care in the hospital, outpatient clinic and the community; clinical trials and uses of devices including Left Ventricular Assist Devices and Cardiac Resynchronization Therapy for heart failure management. He was a member of the Ontario Ministry of Health Task Force on (ICD) Implantable Cardioverter-Defibrillator therapy. In addition to his clinical and research interests he has won several prestigious awards for Clinical Teaching and remains very active in postgraduate medical education. He has been an examiner for the Royal College of Physicians and Surgeons of Canada’s Cardiology Board (1999 – 2007).
He was the Chief of Cardiovascular Services for St Mary’s Regional Cardiac Centre in Kitchener-Waterloo – a full service regional cardiac centre (Sept 2007 – Oct 2013). He is also a member of the Board of Directors for the Cardiac Care Network of Ontario and currently sits on the MOH Expert Panel for Diagnostic Testing as well as Health Care Ontario ‘s Quality Indicators Steering Committee for Heart Failure. He is currently working at Western University, Heart Failure and Transplant services.
Dr. Caren Solomon is a Deputy Editor at the New England Journal of Medicine, where she is responsible for the “Clinical Practice” series (a tri-weekly series of evidence-based review articles relevant to the practicing clinician), original articles related to women's health and general medicine, articles for the “Clinical Problem Solving” series (a monthly series of case discussions), and interactive cases . She is an Associate Professor of Medicine at Harvard Medical School and maintains a part-time clinical practice in Internal Medicine at the Fish Center for Women’s Health at Brigham and Women’s Hospital. Dr. Solomon continues research on a part-time basis, collaborating on epidemiologic and clinical studies of gestational diabetes and other disorders of insulin resistance in women. She graduated from Harvard Medical School and earned an MPH at the Harvard School of Public Health. She completed her internship and residency in internal medicine and fellowship in endocrinology at Brigham and Women’s Hospital.
Dr. Thibodeau-Jarry obtained his MD degree from McGill University in Montreal, Canada in 2009 before completing an internal medicine and a cardiology residency at Université de Montréal. He is presently completing a Master of Medical Sciences in Medical Education at Harvard Medical School, with a particular interest in simulation. He will complete his training with a 1-year fellowship in cardiac echocardiography at the Massachusetts General Hospital from July 2017 to June 2018 before going back to work at the Montreal Heart Institute, where he will help to develop a new simulation center focusing on cardiovascular medicine.
Dr. Thakur completed her medical school at the University of Western Ontario in 2003. She continued her medical training with pediatric residency at the Children’s Hospital of Western Ontario with an additional year of fellowship in pediatric critical care. With a growing interest in cardiology she started a pediatric cardiology fellowship in 2009 at the Stollery Children’s Hospital in Edmonton Alberta. Dr. Thakur completed her cardiology training with an additional year of training in pediatric and fetal echocardiography at the Hospital for Sick Children in 2013. She joined the Hospital for Sick Children as a staff cardiologist in the fetal and pediatric echocardiography lab in 2013. In addition, Dr. Thakur has completed a Master of Science in Health Research Methodology in 2009 at McMaster University. Dr. Thakur also provides pediatric cardiology services at Trillium Health Partners since 2014 including fetal cardiology and inpatient and outpatient cardiology services. Outside of her busy clinical practice, she enjoys spending time with her husband, chasing around her 3 kids, travelling, reading, practicing yoga and attempting to ski. Her clinical Interests include; Clinical epidemiology, pediatric echocardiography, fetal echocardiography, quality improvement in echocardiography and teaching medical students and residents.
Dr. Toma graduated from the University of British Columbia in Vancouver in 2003 and completed training in Internal Medicine and Cardiology at the University of Alberta in Edmonton. He received subspecialty training in Advanced Heart Failure and Cardiac Transplantation at the Cleveland Clinic before completing a Master of Science in Clinical Epidemiology at the Harvard School of Public Health. His clinical interests include advanced heart failure, cardiac transplantation, mechanical circulatory support and cardiac critical care.
Dr. Olga Toleva, MD, MPH, FRCPC, ABIM, is an assistant professor at the University of Manitoba Section of Cardiology and an interventional cardiologist at St. Boniface General Hospital in Winnipeg, Manitoba. Dr. Toleva graduated from the Medical University Sofia, Bulgaria in 1998. She completed her Internal Medicine residency training at the University of British Columbia and her Cardiology residency training at the Mazankowski Alberta Heart Institute, University of Alberta. After having pursued her fellowship training in Interventional Cardiology at the Mazankowski Alberta Heart Institute, University of Alberta, Dr. Toleva has worked in Winnipeg as an interventional cardiologist with specific training in transcatheter aortic valve implantation. In 2015, Dr. Toleva went on to complete a Master of Public Health at Harvard School of Public Health's Program in Clinical Effectiveness.
Dr. Michael Tsang is a Clinical Assistant Professor in the Division of Cardiology at the University of British Columbia. He completed his MD and residency training at the University of British Columbia, and advanced echocardiography and research training at the Mayo Clinic in Rochester, Minnesota. His clinical expertise and research interests include the use of echocardiography for assessing valvular heart disease, and the application of echocardiographic strain imaging in the evaluation of myocardial dysfunction.
Sean Van Diepan
Dr. Sean van Diepen is an academic cardiologist-intensivist. He is currently the Co-Director of the Coronary Intensive Care Unit at the Mazankowski Alberta Heart Institute in Edmonton, and Assistant Professor of Critical Care Medicine in the Department of Critical Care Medicine at the Faculty of Medicine & Dentistry, University of Alberta.
Dr. Atul Verma is a staff cardiac electrophysiologist and Director of Arrhythmia Services at Southlake Regional Health Care Centre in Newmarket, Ontario, Canada. He is affiliated with the University of Toronto and McGill University. Specific interests include ablation of atrial fibrillation and ventricular tachycardia.
Dr. Verma is co-chair of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and serves other international guideline committees.
Dr. Verma completed his medical school and cardiology residency at the University of Toronto and then specialized in cardiac electrophysiology at the Cleveland Clinic. He has published over 150 peer-reviewed articles in the New England Journal of Medicine, Circulation, JACC, JAMA, JAMA Internal Medicine, European Heart Journal, and others.
Dr. Patina Webber is an Emergency Physician and Trauma team Lead at the Royal Jubilee & Victoria General Hospitals. She is co-chair of the Cardiac Arrest/Code Blue Committee for South Vancouver Island and teaches ACLS, PALS, APLS, BLS, ATLS and Advanced Hazmat Life Support. She is the Medical Director for most ACLS courses occurring on South Vancouver Island and has been instrumental in developing a system on Vancouver Island that has brought advanced cardiac care courses to rural and remote locations on the island. She is actively involved in QA, having additionally served on the Pediatric, Trauma and Emergency Quality Assurance Committees.
William Wijns, MD, PhD, FESC, is SFI Professor in Interventional Cardiology at NUIG since October 2016.
Dr. Wijns research efforts are targeting the development and validation of innovative techniques in interventional medicine including invasive and non-invasive physiological measurements and imaging, drug-eluting stents and applications of multi-detector coronary CT angiography.
William is committed to the development and evaluation of novel device-based therapies of cardiovascular diseases.
He served the European Society of Cardiology (ESC) in various positions. Presently, he chairs PCR with focus on adult learning, knowledge transfer techniques and education science via courses and other educational activities (publishing, web-based learning, seminars and workshops).
Professor Wijns is Associate Editor of the European Heart Journal, covering acute coronary syndromes, coronary artery disease and interventional cardiology.
David A. Wood
Dr. David Wood is an Associate Clinical Professor in the Division of Cardiology at the University of British Columbia. He works as a structural and interventional cardiologist at both St. Paul’s and Vancouver General Hospital and is a founding member of the Centre for Heart Valve Innovation (CHVI) in Vancouver. He obtained subspecialty training at Lenox Hill Heart and Vascular Institute of New York. His primary research interests include transcatheter management of structural and valvular heart disease, advanced cardiac imaging, new device development, and novel strategies for treating acute coronary syndromes. Dr. Wood has co-authored over 100 publications in peer reviewed journals including “Current Status of TAVR” in JACC. He is Co-PI for the CIHR funded COMPLETE Trial (n = 4000, 27 countries) and PI for the investigator initiated North American 3M TAVR Study (n = 1200, 10 sites). He was recently selected to receive the 2014 Canadian Cardiovascular Society Young Investigator of the Year Award runner-up in the Clinical Science category.
Elaine Yong joined the team in September 2015 as Senior Communications Specialist in Media Relations. After graduating from Ryerson Polytechnic University in 1995 with a degree in journalism, Elaine spent 20 years as a reporter in television newsrooms across the country, including the last nine years at Global BC. Most recently, she specialized in covering health issues with a keen interest in sharing patients’ stories. Now she’ll be doing much the same thing, just from the other side of the microphone. Elaine is responsible for both proactive and reactive media stories. She is always on the hunt for interesting topics, especially anything that involves making care better for patients.
Dr. Shelley Zieroth joined the Cardiology Section at St. Boniface Hospital in Winnipeg in July 2006. She is currently an Associate Professor in the Department of Medicine, Cardiology Sector, at the University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics. She is also Head of the Medical Heart Failure Program for the Winnipeg Regional Health Authority Cardiac Sciences Program.
Dr. Zieroth attended medical school at the University of Manitoba and went on to train in Internal Medicine and Cardiology at the same centre. She completed her Postdoctoral Clinical Fellowship, specializing in Advanced Heart Failure and Cardiac Transplant, at the Toronto General Hospital.
She is the site principal investigator for several heart failure clinical trials, and an active member of the Canadian Cardiac Transplant Network and the Canadian Cardiovascular Society Primary Panel for Heart Failure Guidelines.
Dr. Sayeh Zielke is a community Adult cardiologist in practising in Lethbridge, Alberta. She is the Medical Director for Chinook Cardiology. She obtained her MD in Ottawa, 2005. After qualifying in Internal Medicine and Cardiology in Calgary, she completed an Echocardiography and Adult Congenital Heart Disease fellowship at the University of Oxford (Oxford, UK) and Royal Brompton Hospital (London, UK).